Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

Condition:   Chorea, Huntington Intervention:   Drug: Valbenazine Sponsors:   Neurocrine Biosciences;   Huntington Study Group Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials